These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27983716)

  • 1. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus.
    Scott SD; Kinsley R; Temperton N; Daly JM
    Pathogens; 2016 Dec; 5(4):. PubMed ID: 27983716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of equine influenza pseudotypes for serological screening.
    Scott S; Molesti E; Temperton N; Ferrara F; Böttcher-Friebertshäuser E; Daly J
    J Mol Genet Med; 2012; 6():304-8. PubMed ID: 23515229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection.
    Kinsley R; Pronost S; De Bock M; Temperton N; Daly JM; Paillot R; Scott S
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32825702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.
    Ferrara F; Molesti E; Böttcher-Friebertshäuser E; Cattoli G; Corti D; Scott SD; Temperton NJ
    J Mol Genet Med; 2012; 7():309-14. PubMed ID: 23577043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of equine influenza virus H3N8 subtype by insulated isothermal RT-PCR (iiRT-PCR) assay using the POCKIT™ Nucleic Acid Analyzer.
    Balasuriya UB; Lee PY; Tiwari A; Skillman A; Nam B; Chambers TM; Tsai YL; Ma LJ; Yang PC; Chang HF; Wang HT
    J Virol Methods; 2014 Oct; 207():66-72. PubMed ID: 24992669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel J; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Feb; 89(3):1652-9. PubMed ID: 25410860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012.
    Alves Beuttemmüller E; Woodward A; Rash A; Dos Santos Ferraz LE; Fernandes Alfieri A; Alfieri AA; Elton D
    Virol J; 2016 Mar; 13():45. PubMed ID: 26993620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the virulence of a recombinant influenza virus expressing the naturally truncated NS gene from an H3N8 equine influenza virus in mice.
    Na W; Lyoo KS; Yoon SW; Yeom M; Kang B; Moon H; Kim HK; Jeong DG; Kim JK; Song D
    Vet Res; 2016 Nov; 47(1):115. PubMed ID: 27846859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.
    Zhang W; Li W; Li Y; Li H; Wang B; Wang F; Zhu Y; Jiang Z; Zhong L; Li M
    J Med Microbiol; 2009 Jul; 58(Pt 7):845-854. PubMed ID: 19498203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
    Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
    J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine failure caused an outbreak of equine influenza in Croatia.
    Barbic L; Madic J; Turk N; Daly J
    Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine influenza outbreak in India (2008-09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene.
    Virmani N; Bera BC; Singh BK; Shanmugasundaram K; Gulati BR; Barua S; Vaid RK; Gupta AK; Singh RK
    Vet Microbiol; 2010 Jul; 143(2-4):224-37. PubMed ID: 20053509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Genetic Characterization of H3N8 Equine Influenza Virus Responsible for Clinical Disease in Algeria in 2011.
    Laabassi F; Lecouturier F; Amelot G; Gaudaire D; Mamache B; Laugier C; Legrand L; Zientara S; Hans A
    Transbound Emerg Dis; 2015 Dec; 62(6):623-31. PubMed ID: 24472362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007.
    Bryant NA; Rash AS; Russell CA; Ross J; Cooke A; Bowman S; MacRae S; Lewis NS; Paillot R; Zanoni R; Meier H; Griffiths LA; Daly JM; Tiwari A; Chambers TM; Newton JR; Elton DM
    Vet Microbiol; 2009 Jul; 138(1-2):41-52. PubMed ID: 19346084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.